Drug intelligence / Profile preview

alpha-pinene

Development stage
Phase 1
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, Inhalation, Transdermal
01

Overview

Alpha-pinene is a naturally occurring monoterpene and one of the most abundant terpenes found in nature, especially in pine resin and many plant essential oils. It is used experimentally, often in combination with other plant-derived compounds, for the treatment of bladder, kidney, and urinary stones[1]. Alpha-pinene exhibits a wide range of pharmacological activities including antimicrobial, antitumor (notably against various cancer cell lines), antioxidant, anti-inflammatory, analgesic, anticoagulant, antimalarial effects as well as neuroprotective properties[2][4]. Mechanistically, it has been shown to inhibit inflammatory pathways such as mitogen-activated protein kinases (MAPK) and nuclear factor-kappa B (NF-κB) in macrophages[4], modulate oxidative stress responses[6], induce cell cycle arrest at G2/M phase via downregulation of miR-221 expression leading to activation of CDKN1B/p27-CDK1 and ATM-p53-Chk2 pathways in cancer cells[2], and exert fungicidal activity through ergosterol complexation in fungal membranes[6]. Alpha-pinene also enhances drug skin penetration and may have synergistic effects with certain chemotherapeutics. Its use is primarily experimental or as a component of dietary supplements.

Other names
α-pinenepin-2(3)-ene
02

Targets

BZD site (GABA-A receptor benzodiazepine site)Mpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on alpha-pinene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-pinene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call